Local Treg Immunomodulation Cures Metastatic Lymphoma Including CNS Sites

Abstract LBA-2 CD4+CD25+FOXP3+ regulatory T-cells (Tregs) protect cancers from the immune system. They express important functional molecules such as CTLA-4 and Ox40 on their surface. Anti-CTLA4 monoclonal antibody (mAb) is the first drug to improve survival of refractory metastatic melanoma. Its re...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 118; no. 21; p. LBA-2
Main Authors Marabelle, Aurelien, Kohrt, Holbrook E, Brody, Joshua, Torchia, James Anthony, Zhou, Gang, Luong, Richard, Rajapaksa, Ranjani, Tse, Victor, Levy, Ronald
Format Journal Article
LanguageEnglish
Published Elsevier Inc 18.11.2011
Online AccessGet full text

Cover

Loading…